Bioinformatic analysis of glycogen synthase kinase 3: Human versus parasite kinases

Parasitology

Volumn 138, Issue 6, 2011, Pages 725-735

  Osolodkin, Dmitry I ^a   Zakharevich, Natalia V ^b   Palyulin, Vladimir A ^a   Danilenko, Valery N ^b,c   Zefirov, Nikolay S ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^c Antibiotic Biotechnology Research Center   (Russian Federation)

Author keywords

bioinformatics; filariasis; glycogen synthase kinase 3; GSK 3; leishmaniasis; malaria; molecular modelling; neglected diseases; schistosomiasis; trypanosomiasis; Wnt pathway

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING SITE; ENZYME ACTIVE SITE; ENZYME STRUCTURE; FUNGUS; GENE DELETION; GENE INSERTION; GENETIC CONSERVATION; GENETIC SIMILARITY; HUMAN; INSECT; MAMMAL; MOLECULAR MODEL; NEMATODE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTOZOON; REVIEW; SEQUENCE ALIGNMENT; SPECIES COMPARISON; TREMATODE;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIPARASITIC AGENTS; BINDING SITES; COMPUTATIONAL BIOLOGY; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LEISHMANIA DONOVANI; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PARASITES; PLASMODIUM FALCIPARUM; PROTEIN KINASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; TRYPANOSOMA BRUCEI BRUCEI;

FUNGI; HEXAPODA; LEISHMANIA DONOVANI; MAMMALIA; NEMATODA; PLASMODIUM FALCIPARUM; PROTOZOA; TREMATODA; TRYPANOSOMA BRUCEI;

EID: 79956047327     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182011000151     Document Type: Review

References (48)

1. Ashkenazy, H., Erez, E., Martz, E., Pupko, T. and Ben-Tal, N. (2010). ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Research 38 (Web Server issue), W529-W533. doi: 10.1093/nar/gkq399.
2. Avila, J., Wandosell, F. and Hernández, F. (2010). Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors. Expert Review of Neurotherapeutics 10, 703-710. doi: 10.1586/ern.10.40.
3. Bertrand, J. A., Thieffine, S., Vulpetti, A., Cristiani, C., Valsasina, B., Knapp, S., Kalisz, H. M. and Flocco, M. (2003). Structural characterization of the GSK-3â active site using selective and non-selective ATPmimetic inhibitors. Journal of Molecular Biology 333, 393-407. doi: 10.1016/j.jmb.2003. 08.031. (Pubitemid 37188580)
4. Bhat, R., Xue, Y., Berg, S., Hellberg, S., Ormö, M., Nilsson, Y., Radesäter, A.-C., Jerning, J., Markgren, P.-O., Borgregård, T., Nylöf, M., Giménez-Cassina, A., Hernández, F., Lucas, J. J., Díaz-Nido, J. and Avila, J. (2003). Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. The Journal of Biological Chemistry 278, 45937-45945. doi: 10.1074/jbc. M306268200. (Pubitemid 37432740)
5. Canduri, F., Perez, P. C., Caceres, R. A. and de Azevedo, W. F. Jr. (2007). Protein kinases as targets for antiparasitic chemotherapy drugs. Current Drug Targets 8, 389-398. (Pubitemid 46381291)
6. Chellan, G., Shivaprakash, S., Ramaiyar, S. K., Varma, A. K., Varma, N., Sukumaran, M. T., Vasukutty, J. R., Bal, A. and Kumar, H. (2010). Spectrum and Prevalence of Fungi Infecting Deep Tissues of Lower-Limb Wounds in Patients with Type 2 Diabetes. Journal of Clinical Microbiology 48, 2097-2102. doi: 10.1128/JCM.02035-09.
7. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C. and Pearl, L. H. (2001). Crystal structure of glycogen synthase kinase 3â: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732. doi: 10.1016/S0092-8674(01)00374-9. (Pubitemid 32635102)
8. Dajani, R., Fraser, E., Roe, S. M., Yeo, M., Good, V. M., Thompson, V., Dale, T. C. and Pearl, L. H. (2003). Structural basis for recruitment of glycogen synthase kinase 3â to the axin-APC scaffold complex. The EMBO Journal 22, 494-501. doi: 10.1093/emboj/cdg068. (Pubitemid 36193594)
9. Droucheau, E., Primot, A., Thomas, V., Mattei, D., Knockaert, M., Richardson, C., Sallicandro, P., Alano, P., Jafarshad, A., Baratte, B., Kunick, C., Parzy, D., Pearl, L., Doerig, C. and Meijer, L. (2004). Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors. Biochimica et Biophysica Acta 1607, 181-196. doi: 10.1016/j.bbapap.2003.11.023. (Pubitemid 38326771)
10. Dugo, L., Collin, M. and Thiemermann, C. (2007). Glycogen synthase kinase 3â as a target for the therapy of shock and inflammation. Shock 27, 113-123. doi: 10.1097/01.shk.0000238059.23837.68. (Pubitemid 46105826)
11. Embi, N., Rylatt, D. B. and Cohen, P. (1980). Glycogen synthase kinase-3 from rabbit skeletal muscle. European Journal of Biochemistry 107, 519-527. doi: 10.1111/j.1432-1033.1980.tb06059.x.
12. Fabres, A., Pinto de Andrade, C., Guizzo, M., Sorgine, M.H. F., Paiva-Silva, G. D. O., Masuda, A., Da Silva Vaz, I. Jr. and Logullo, C. (2010). Effect of GSK-3 activity, enzymatic inhibition and gene silencing by RNAi on tick oviposition and egg hatching. Parasitology 137, 1537-1546. doi: 10.1017/S0031182010000284.
13. Frame, S. and Zheleva, D. (2006). Targeting glycogen synthase kinase-3 in insulin signalling. Expert Opinion on Therapeutic Targets 10, 429-444. doi: 10.1517/14728222.10.3.429. (Pubitemid 43949957)
14. Gamo, F.-J., Sanz, L. M., Vidal, J., de Cozar, C., Alvarez, E., Lavandera, J.-L., Vanderwall, D. E., Green, D. V. S., Kumar, V., Hasan, S., Brown, J. R., Peishoff, C. E., Cardon, L. R. and Garcia-Bustos, J. F. (2010). Thousands of chemical starting points for antimalarial lead identification. Nature, London 465, 305-310. doi: 10.1038/nature09107.
15. Glaser, F., Pupko, T., Paz, I., Bell, R. E., Bechor, D., Martz, E. and Ben-Tal, N. (2003). ConSurf: Identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19, 163-164. doi: 10.1093/bioinformatics/19.1.163. (Pubitemid 36150199)
16. Henriksen, E. J. and Dokken, B. B. (2006). Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Current Drug Targets 7, 1435-1441. (Pubitemid 44718303)
17. Hoskins, R. A., Carlson, J.W., Kennedy, C., Acevedo, D., Evans-Holm, M., Frise, E., Wan, K. H., Park, S., Mendez-Lago, M., Rossi, F., Villasante, A., Dimitri, P., Karpen, G. H. and Celniker, S. E. (2007). Sequence finishing and mapping of Drosophila melanogaster heterochromatin. Science 316, 1625-1628. doi: 10.1126/science.1139816. (Pubitemid 46982037)
18. Ibrahim, M. A., Shilabin, A. G., Prasanna, S., Jacob, M., Khan, S. I., Doerksen, R. J. and Hamann, M. T. (2008). 2-N-methyl modifications and SAR studies of manzamine A. Bioorganic and Medicinal Chemistry 16, 6702-6706. doi: 10.1016/j.bmc.2008.05.079.
19. Kassir, Y., Rubin-Bejerano, I. and Mandel-Gutfreund, Y. (2006). The Saccharomyces cerevisiae GSK-3â homologs. Current Drug Targets 7, 1455-1465.
20. Kruggel, A. and Lemcke, T. (2009a). Comparative investigation of the ATP-binding site of human and plasmodial glycogen synthase kinase-3. QSAR and Combinatorial Science 28, 885-890. doi: 10.1002/ qsar.200860193.
21. Kruggel, A. and Lemcke, T. (2009b). Generation and evaluation of a homology model of PfGSK-3. Archiv der Pharmazie -Chemistry in Life Sciences 342, 327-332. doi: 10.1002/ardp.200800158.
22. Kurosu, M. and Begari, E. (2010). Bacterial protein kinase inhibitors. Drug Development Research 71, 168-187. doi: 10.1002/ddr.20362.
23. Landau, M., Mayrose, I., Rosenberg, Y., Glaser, F., Martz, E., Pupko, T. and Ben-Tal, N. (2005). ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Research 33 (Web Server issue), W299-W302. doi: 10.1093/nar/ gki370. (Pubitemid 44529930)
24. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J. D., Gibson, T. J. and Higgins, D. G. (2007). Clustal Wand Clustal X version 2.0. Bioinformatics 23, 2947-2948. doi: 10.1093/bioinformatics/btm404. (Pubitemid 350162903)
25. Laskowski, R. A., MacArthur, M.W., Moss, D. S. and Thornton, J.M. (1993). PROCHECK -a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography 26, 283-291. doi: 10.1107/S0021889892009944.
26. Liang, M.-H. and Chuang, D.-M. (2006). Differential Roles of Glycogen Synthase Kinase-3 Isoforms in the Regulation of Transcriptional Activation. The Journal of Biological Chemistry 281, 30479-30484. doi: 10.1074/jbc.M607468200. (Pubitemid 44582104)
27. Liotta, F. and Siekierka, J. J. (2010). Apicomplexa, trypanosoma and parasitic nematode protein kinases as antiparasitic therapeutic targets. Current Opinion in Investigational Drugs 11, 147-156.
28. Lochhead, P. A., Kinstrie, R., Sibbet, G., Rawjee, T., Morrice, N. and Cleghon, V. (2006). A chaperone-dependent GSK3â transitional intermediate mediates activation-loop autophosphorylation. Molecular Cell 24, 627-633. doi: 10.1016/j.molcel.2006.10.009. (Pubitemid 350284229)
29. Logullo, C., Witola, W. H., Andrade, C., Abreu, L., Gomes, J., da Silva Vaz, I. Jr., Imamura, S., Konnai, S., Ohashi, K. and Onuma, M. (2009). Expression and activity of glycogen synthase kinase during vitellogenesis and embryogenesis of Rhipicephalus (Boophilus) microplus. Veterinary Parasitology 161, 261-269. doi: 10.1016/j.vetpar. 2009.01.029.
30. Martinez, A., Alonso, M., Castro, A., Dorronsoro, I., Gelpí, J. L., Luque, F. J., Pérez, C. and Moreno, F. J. (2005). SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors. Journal of Medicinal Chemistry 48, 7103-7112. doi: 10.1021/jm040895g. (Pubitemid 41743624)
31. Meijer, L., Skaltsounis, A.-L. L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A. A., Brivanlou, A., Dajani, R., Crovace, C., Tarricone, C., Musacchio, A., Roe, S. M., Pearl, L. and Greengard, P. (2003). GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chemistry and Biology 10, 1255-1266. doi:10.1016/j.chembiol.2003.11. 010. (Pubitemid 38050973)
32. Nicholas, K. B., Nicholas, H. B. Jr. and Deerfield II, D.W. (1997). GeneDoc: analysis and visualization of genetic variation. EMBnet.news 4, 14-17.
33. Ojo, K. K., Gillespie, J. R., Riechers, A. J., Napuli, A. J., Verlinde, C. L. M. J., Buckner, F. S., Gelb, M. H., Domostoj, M. M., Wells, S. J., Scheer, A., Wells, T. N. C. and Van Voorhis, W. C. (2008). Glycogen synthase kinase 3 is a potential drug target for african trypanosomiasis therapy. Antimicrobial Agents and Chemotherapy 52, 3710-3717. doi:10.1128/AAC.00364-08.
34. Ougolkov, A. V. and Billadeau, D. D. (2006). Targeting GSK-3: a promising approach for cancer therapy? Future Oncology 2, 91-100. doi: 10.2217/14796694.2.191.
35. Patel, S. and Woodgett, J. (2008). Glycogen syntase kinase-3 and cancer: good cop, bad cop? Cancer Cell 14, 351-353. doi: 10.1016/j.ccr.2008.10.013.
36. Peng, J., Kudrimoti, S., Prasanna, S., Odde, S., Doerksen, R. J., Pennaka, H. K., Choo, Y.-M., Rao, K. V., Tekwani, B. L., Madgula, V., Khan, S. I., Wang, B., Mayer, A. M. S., Jacob, M. R., Tu, L. C., Gertsch, J. and Hamann, M. T. (2010). Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections. Journal of Medicinal Chemistry 53, 61-76. doi: 10.1021/jm900672t.
37. Qin, C., Tang, J. and Kim, K. (1998). Cloning and in vitro expression of TPK3, a Toxoplasma gondii homologue of shaggy/glycogen synthase kinase-3 kinases. Molecular and Biochemical Parasitology 93, 278-283. doi: 10.1016/ S0166-6851(98)00042-5.
38. Rayasam, G. V., Tulasi, V. K., Sodhi, R., Davis, J. A. and Ray, A. (2009). Glycogen synthase kinase 3: more than a namesake. British Journal of Pharmacology 156, 885-898. doi: 10.1111/j.1476-5381.2008.00085.x.
39. Šali, A. and Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology 234, 779-815. doi: 10.1006/jmbi.1993.1626. (Pubitemid 24007801)
40. Sippl, M. J. (1993). Recognition of errors in three-dimensional structures of proteins. PROTEINS: Structure, Function and Genetics 17, 355-362. doi: 10.1002/prot.340170404. (Pubitemid 23358545)
41. Tamura, K., Dudley, J., Nei, M. and Kumar, S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Molecular Biology and Evolution 24, 1596-1599. doi:10.1093/molbev/ msm092. (Pubitemid 47236692)
42. Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B. and Rincon, M. (2008). Phosphorylation by p38 MAPKas an Alternative Pathway for GSK3â Inactivation. Science 320, 667-670. doi: 10.1126/science.1156037. (Pubitemid 351928349)
43. Wu, D. and Pan,W. (2009). GSK3: a multifaceted kinase in Wnt signaling. Trends in Biochemical Sciences 35, 161-168. doi: 10.1016/j.tibs.2009.10.002.
44. Xiao, J.-F., Li, Z.-S., Sun, M., Zhang, Y. and Sun, C.-C. (2004). Homology modeling and molecular dynamics study of GSK3/SHAGGYlike kinase. Computational Biology and Chemistry 28, 179-188. doi: 10.1016/ j.compbiolchem.2004.02.003.
45. Xingi, E., Smirlis, D., Myrianthopoulos, V., Magiatis, P., Grant, K. M., Meijer, L., Mikros, E., Skaltsounis, A.-L. and Soteriadou, K. (2009). 6-Br-5methylindirubin-3'OElig;oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis. International Journal for Parasitology 39, 1289-1303. doi: 10.1016/j.ijpara. 2009.04.005.
46. Zhang, J., Yang, P. L. and Gray, N. S. (2009a). Targeting cancer with small molecule linase inhibitors. Nature Reviews Cancer 9, 28-39. doi: 10.1038/nrc2559.
47. Zhang, N., Jiang, Y., Zou, J., Yu, Q. and Zhao, W. (2009b). Structural basis for the complete loss of GSK3â catalytic activity due to R96 mutation investigated by molecular dynamics study. PROTEINS: Structure, Function and Bioinformatics 75, 671-681. doi: 10.1002/prot.22279.
48. Zuccotto, F., Ardini, E., Casale, E. and Angiolini, M. (2010). Through the "Gatekeeper Door": Exploiting the Active Kinase Conformation. Journal of Medicinal Chemistry 53, 2681-2694. doi: 10.1021/jm901443h.